CHA2DS2-VASC SCORE AND ADVERSE EVENTS IN PATIENTS WITH HEART FAILURE AND SINUS RHYTHM

Siqin Ye; Min Qian; Bo Zhao; Professor Gregory Lip; Richard Buchsbaum; Ralph L. Sacco; Bruce Lubotsky Levin; Marco Di Tullio; Douglas L. Mann; Patrick Pullicino; Ronald S. Freudenberger; John R. Teerlink; J.P. Mohr; Susan Graham; Arthur J. Labovitz; Conrado J. Estol; Dirk J. Lok; Piotr Ponikowski; Stefan D. Anker; John L.P. Thompson; Shunichi Homma

doi:10.1016/s0735-1097(16)31336-5

Related publications

Article2016

CHA2DS2-VASc Score and Adverse Outcomes in Patients with Heart Failure with Reduced Ejection Fraction and Sinus Rhythm

Siqin Ye, Min Qian, Bo Zhao, Richard Buchsbaum, Ralph L. Sacco, Bruce Levin, Marco R. Di Tullio, Douglas L. Mann, Patrick M. Pullicino, Ronald S. Freudenberger, John R. Teerlink, J.P. Mohr, Susan Graham, Arthur J. Labovitz, Conrado J. Estol, Dirk J. Lok, Piotr Ponikowski, Stefan D. Anker, Professor Gregory Lip, John L.P. Thompson, Shunichi Homma

Letter2022

Stroke risk stratification in patients with heart failure and sinus rhythm

Dimitrios Sagris, Eduard Shantsila, Professor Gregory Lip

Article2021

Anticoagulation versus placebo for heart failure in sinus rhythm

Eduard Shantsila, Monika Kozieł, Professor Gregory Lip

Article2015

Clinical characteristics and predictors of one-year outcome of heart failure patients with atrial fibrillation compared to heart failure patients in sinus rhythm

Krzysztof Ozierański, Agnieszka Kapłon‐Cieślicka, Michał Peller, Agata Tymińska, Paweł Balsam, Michalina Galas, Michał Marchel, María G. Crespo‐Leiro, Aldo Maggioni, Jarosław Dróżdż, Grzegorz Opolski

Article2025

Antiplatelet versus anticoagulation treatment for people with heart failure in sinus rhythm

Monika Kozieł-Siołkowska, Eduard Shantsila, Alena Shantsila, Professor Gregory Lip